| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $59.8M | -62.3% |
| SG&A Expense | $65.6M | +77.9% |
| Operating Income | -$125.4M | +35.9% |
| Pre-tax Income | -$110.6M | +43.5% |
| Income Tax | -$333K | -164.3% |
| Net Income | -$110.3M | +43.8% |
| EPS (Basic) | -$1.02 | +82.1% |
| EPS (Diluted) | -$1.02 | +82.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.2M | -65.3% |
| Short-term Investments | $223.1M | +43.9% |
| Current Assets | $312.8M | -21.7% |
| Total Assets | $320.0M | -25.0% |
| Current Liabilities | $23.6M | +56.5% |
| Total Liabilities | $26.3M | -32.5% |
| Stockholders' Equity | $259.9M | -26.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$99.2M | +39.5% |
| Capital Expenditures | $1.8M | +94.8% |
| Investing Cash Flow | -$69.2M | +55.6% |
| Financing Cash Flow | $1.7M | -99.5% |
| Free Cash Flow | -$101.0M | +38.7% |